As of April 2025 Novavax has a market cap of โน81.10 Billion. This makes Novavax the world's 5465th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โน81.10 B | -28.72% |
2024 | โน113.78 B | 139.7% |
2023 | โน47.46 B | -34.36% |
2022 | โน72.31 B | -91.02% |
2021 | โน805.14 B | 55.09% |
2020 | โน519.15 B | 5553.97% |
2019 | โน9.18 B | -81.44% |
2018 | โน49.46 B | 66.42% |
2017 | โน29.72 B | 27.98% |
2016 | โน23.22 B | -84.57% |
2015 | โน150.52 B | 67.7% |
2014 | โน89.76 B | 36% |
2013 | โน66.00 B | 331.1% |
2012 | โน15.30 B | 99.78% |
2011 | โน7.66 B | -36.62% |
2010 | โน12.09 B | -2.3% |
2009 | โน12.37 B | 96.94% |
2008 | โน6.28 B | -22.39% |
2007 | โน8.09 B | -27.85% |
2006 | โน11.22 B | 18.33% |
2005 | โน9.48 B | 69.81% |
2004 | โน5.58 B | -41.12% |
2003 | โน9.48 B | 204.61% |
2002 | โน3.11 B | -80.35% |
2001 | โน15.84 B | 80.73% |
2000 | โน8.76 B | 136.43% |
1999 | โน3.70 B | 271.02% |
1998 | โน0.99 B | -57.65% |
1997 | โน2.36 B | 79.13% |
1996 | โน1.31 B |
On Apr 11th, 2025 the market cap of Novavax was reported to be: